Inventor · disambiguated record
Gilles Gadea
Also filed as: GADEA GILLES
10 granted patents·4 pending applications·46 citations·filing 2003–2024
86Inventor score
Files withABIVAX7CENTRE NAT RECH SCIENT2INST NAT SANTE RECH MED2ROUX PIERRE2CT NATIONALE DE RECH SCIENT1
Top patents by PatentIndex Score
14 records- 0194US10253020B2Compounds for preventing, inhibiting, or treating cancer, AIDS and/or premature agingABIVAX·Filed 2017·Granted Apr 9, 2019·8 cites·13 claims
- 0293US9637475B2Compounds for treating cancerABIVAX·Filed 2015·Granted May 2, 2017·13 cites·27 claims
- 0390US9108919B2Compounds useful for treating cancerCT NATIONALE DE RECH SCIENT·Filed 2013·Granted Aug 18, 2015·18 cites·10 claims
- 0483US9969715B2Compounds useful for treating cancerABIVAX·Filed 2013·Granted May 15, 2018·5 cites·8 claims
- 0579US10717724B2Compounds useful for treating cancerABIVAX·Filed 2018·Granted Jul 21, 2020·1 cites·15 claims
- 0674US2024343716A1Compounds for preventing, inhibiting, or treating cancer, aids and/or premature agingABIVAX·Filed 2024·Application pending·0 cites
- 0770US10849943B2Vaccine compositions comprising an attenuated mutant Zika virusINST NAT SANTE RECH MED·Filed 2017·Granted Dec 1, 2020·1 cites·15 claims
- 0863US11427566B2Compounds useful for treating cancerABIVAX·Filed 2020·Granted Aug 30, 2022·0 cites·16 claims
- 0963US2022127253A1Compounds for preventing, inhibiting, or treating cancer, aids and/or premature agingABIVAX·Filed 2021·Application pending·0 cites
- 1060US12227767B2Delta133P53Beta and Delta133P53Gamma isoforms are biomarkers of cancer stem cellsCENTRE NAT RECH SCIENT·Filed 2021·Granted Feb 18, 2025·0 cites·11 claims
- 1151US10920198B2Delta133p53beta and delta133p53gamma isoforms are biomarkers of cancer stem cellsCENTRE NAT RECH SCIENT·Filed 2016·Granted Feb 16, 2021·0 cites·6 claims
- 1251US10590174B2Genomic sequences encoding for an attenuated mutant Zika virusINST NAT SANTE RECH MED·Filed 2017·Granted Mar 17, 2020·0 cites·13 claims
- 1343US2006127957A1Novel biologicalcancer marker and methods for determining the cancerous or non-cancerous phenotype of cellsROUX PIERRE·Filed 2003·Application pending·0 cites
- 1438US2012115151A1Method for testing a subject thought to be predisposed to having metastatic cancer using delta133p53betaROUX PIERRE·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gilles Gadea files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →